Abrams Capital Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
OFM
LCM
DFO
Abrams Capital Management's NUVB Position: Q2 2026 in Review
Abrams Capital Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 1,270,504 shares worth $7.22M. The position accounts for 0.13% of the portfolio, ranked #10.
Abrams Capital Management first reported a position in NUVB in Q1 2021 and has held it in 22 quarters since. The position peaked at $37.9M in Q3 2021. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- Abrams Capital Management held 1,270,504 shares of Nuvation Bio worth $7.22M as of Q2 2026.
- Abrams Capital Management left its Nuvation Bio share count unchanged in Q2 2026.
- Nuvation Bio made up 0.13% of Abrams Capital Management's portfolio in Q2 2026, its #10 holding.
- Abrams Capital Management first reported a position in Nuvation Bio in Q1 2021 and has held it in 22 quarters since.
- Abrams Capital Management's Nuvation Bio position peaked at $37.9M in Q3 2021.
- 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on Abrams Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.